ArticleCancer science2023

Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinoma.

Wataru Fukumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.